JPRN-UMIN000001826未知3 期
Randomized phase III trial of Docetaxel versus docetaxel plus S-1 for second-line treatment of non-small cell lung cancer (NSCLC) - Randomized phase III trial of Docetaxel versus docetaxel plus S-1 for second-line treatment of non-small cell lung cancer (NSCLC)
The Japan-multinational Trial Organization0 个研究点目标入组 860 人开始时间: 2009年3月31日最近更新:
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 860
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) Patients with serious infections or suspected infections with fever. 2) Pregnant or lactating women 3) Active concomitant malignancy 4) sever allergy 5) Active ineterstitial pneumonitis 6) The prior treatment is a case only of the molecular-targeted agent. 7) Symptomatic brain metastasis 8) History of using 5-FU or docetaxel 9) Inappropriate patients for this study judged by the physicians.
研究者
相似试验
招募中
3 期
Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)10038597prostate cancerNL-OMON54758Memorial Sloan Kettering Cancer Center250
进行中（未招募）
1 期
Trial comparing subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC) treated with Docetaxel vs. subjects treated with a combination of Docetaxel and Radium-223Patients with histological or cytological proof of Metastatic Castration-Resistant Prostate Cancer (mCRPC)EUCTR2018-002944-10-NLMemorial Sloan Kettering Cancer Center738
进行中（未招募）
不适用
A Phase III Randomized Trial of Docetaxel Based Induction Chemotherapy in Patients with N2/N3 Locally Advanced Head and Neck CancerEstudio de fase III randomizado de una quimioterapia de inducción basada en el Docetaxel en pacientes con cáncer de cabeza y cuello localmente avanzado N2/N3 (DeCIDE) - DeCIDEPhase III trial of induction therapy with docetaxel followed by chemoradiotherapy versus chemoradiotherapy alone in patients with nodal stage N2 or N3 head and neck cancerEUCTR2006-002335-24-ESniversity of Chicago400
已完成
不适用
Randomized Phase II Trial Comparing Docetaxel with weekly Paclitaxel and Carboplatin in Elderly Patients with Non-Small Cell Lung CancerJPRN-UMIN000002616Tohoku University Hospital80
进行中（未招募）
1 期
A Phase III Trial Comparing Docetaxel Every Third Week to Biweekly Docetaxel Monotherapy in Metastatic Hormone Refractory Prostate Cancer. - PROSTY trialMetastatic Hormone Refractory Prostate Cancer.MedDRA version: 8.1Level: PTClassification code 10060862Term: Prostate cancerEUCTR2004-004295-37-IEAll-Ireland Cooperative Oncology Research Group360